Skip to main content
. Author manuscript; available in PMC: 2020 Apr 6.
Published in final edited form as: Ann Thorac Surg. 2018 Oct 11;107(2):363–368. doi: 10.1016/j.athoracsur.2018.08.057

Table 2.

Univariate analysis of patient characteristics and new persistent opioid usage.

Variable No Persistent Use, Total n = 2602 Persistent Opioid Use, Total n = 424 P-value
Age ≤ 64 years* 1345 (51.7%) 245 (57.8%) 0.021

Male sex* 1130 (43.4%) 226 (53.3%) <0.001

Income ≤ $70,000* 1715 (65.9%) 311 (73.3%) 0.003

Anxiety 198 (7.6%) 29 (7.8%) 0.620

Depression 147 (5.6%) 26 (6.1%) 0.653

Substance Abuse* 423 (16.3%) 95 (22.4%) 0.003

Neoadjuvant Therapy 164 (6.3%) 32 (7.5%) 0.338

Surgical Approach
 Thoracotomy* 1428 (54.8%) 294 (69.3%)
 VATS 1126 (43.2%) 117 (27.6%) <0.001
 Unknown 48 (1.8%) 13 (3.1%)

Postoperative Length of Stay > 5 days* 852 (32.7%) 188 (44.3%) <0.001

Adjuvant Therapy* 500 (19.2%) 157 (37.0%) <0.001

VATS, video-assisted thoracoscopic surgery. All variables marked with

*

were significant on univariate analysis and included in multivariable binary regression model.